TSHA News & Analysis

Taysha Gene Therapies (TSHA) Stock Reaches All-Time High of 5.49 USD

Taysha Gene Therapies (TSHA) stock has reached an all-time high of 5.49 USD. This increase represents a significant milestone for the company, potentially impacting investor sentiment and market perception. The rise in stock price may attract attention from both institutional and retail investors. It reflects investor confidence in the company's future performance and therapeutic developments.